Sec. 605. Reauthorization of provision pertaining to drugs containing single enantiomers
47 words·~1 min read·
/bill/117/s/4348/rs/section-605A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 505(u) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(u) ) is amended by— in paragraph (1)(A)(ii)(II), by adding (other than bioavailability studies) after any clinical investigations ; and in paragraph (4), by striking October 1, 2022 and inserting October 1, 2027 .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 605
Reauthorization of provision pertaining to drugs containing single enantiomers
Cites 1Cited by 0 across 0 sources